Joining VeloClub not only supports the work we do, there are some fantastic benefits:
by Mark Zalewski
September 27, 2016
In today’s CyclingTips Daily News Digest: Brailsford breaks silence about Wiggins’ TUEs; Froome says he did not know about Wiggins’ TUEs; Dumoulin reacts to Wiggins TUE controversy; Commentary: Jingle Cross was Christmas in September for US cyclocross fans; Serbian rider Dejan Maric dies in road race; Feline extends, Cardoso signs with Trek-Segafrdo; Nibali back from collarbone injury, but to miss Il Lombardia; Cylance adds Willeke Knol and Malgorzata Jasinska for 2017; Boonen, Van Avermaet, D’Hoore lead Belgians at Road Worlds; Dutch announce road worlds team; Bouhanni, Demare for French in Road Worlds; Social media calls new British cycle safety campaign ‘victim blaming’; Zwift sponsors Africa Kit Appeal; Video: Catching up with the woman who went 235km/hr (147 mph) on a bicycle; Katie Compton post-Iowa interview.
The cycling world’s attention is on Bradley Wiggins and Team Sky over the British rider’s use of the corticosteroid Triamcinolone acetonide, in particular during his Tour de France win in 2012. During that Tour he had a highly-visable falling out with Chris Froome, his teammate at the time, who was supposed to ride in support of Wiggins as he became the first British winner. Now Froome has said he did not know about Wiggins’ Therapeutic Use Exemption (TUE).
The Telegraph reports that Froome only learned about Wiggins’ injections of the powerful steroid due to the recent data leak by hackers.
The data leaks have also revealed Froome’s TUEs, one for prednisolone, another type of corticosteroid, which he took orally in 2013 and 2014. The 2014 TUE has raised some eyebrows as he went on to win the Tour of Romandie. However, he had a well-documented chest infection at the time.
This has many revisiting stage 17 of the 2012 Tour de France when Froome was clearly the stronger rider on the final ascent, but was held back by Team Sky to support Wiggins.
Click through to read more at The Telegraph.